722 related articles for article (PubMed ID: 18227495)
21. Adverse effect of the disturbances of glycemia and insulimemia on model PC12 cells - preliminary report.
Rorbach-Dolata A; Piwowar A
Pediatr Endocrinol Diabetes Metab; 2017; 23(4):174-180. PubMed ID: 29574469
[TBL] [Abstract][Full Text] [Related]
22. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Baretić M; Troskot R
Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
[TBL] [Abstract][Full Text] [Related]
23. Hyperinsulinemia and its impact on obesity and insulin resistance.
Cusin I; Rohner-Jeanrenaud F; Terrettaz J; Jeanrenaud B
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S1-11. PubMed ID: 1338381
[TBL] [Abstract][Full Text] [Related]
24. Hypothesis: Musculin is a hormone secreted by skeletal muscle, the body's largest endocrine organ. Evidence for actions on the endocrine pancreas to restrain the beta-cell mass and to inhibit insulin secretion and on the hypothalamus to co-ordinate the neuroendocrine and appetite responses to exercise.
Engler D
Acta Biomed; 2007; 78 Suppl 1():156-206. PubMed ID: 17465332
[TBL] [Abstract][Full Text] [Related]
25. Soluble insulin receptor and metabolic syndrome.
Hiriart-Urdanivia M; Sánchez-Soto C; Velasco M; Sabido-Barrera J; Ortiz-Huidobro RI
Gac Med Mex; 2019; 155(5):500-503. PubMed ID: 32091018
[TBL] [Abstract][Full Text] [Related]
26. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].
Valensi P
Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099
[TBL] [Abstract][Full Text] [Related]
27. Exogenous glucocorticoids and a high-fat diet cause severe hyperglycemia and hyperinsulinemia and limit islet glucose responsiveness in young male Sprague-Dawley rats.
Beaudry JL; D'souza AM; Teich T; Tsushima R; Riddell MC
Endocrinology; 2013 Sep; 154(9):3197-208. PubMed ID: 23766132
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of insulin resistance and hyper-insulinemia in fatty liver.
Ibrahim KM; Nicola WG; Salama SH
Boll Chim Farm; 1996 Oct; 135(9):528-40. PubMed ID: 9035563
[TBL] [Abstract][Full Text] [Related]
29. Role of insulin resistance in human disease (syndrome X): an expanded definition.
Reaven GM
Annu Rev Med; 1993; 44():121-31. PubMed ID: 8476236
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity.
Psyrogiannis AJ; Alexopoulos DK; Kyriazopoulou VE; Vagenakis AG
Angiology; 1998 Aug; 49(8):607-12. PubMed ID: 9717889
[TBL] [Abstract][Full Text] [Related]
31. Vagotomy ameliorates islet morphofunction and body metabolic homeostasis in MSG-obese rats.
Lubaczeuski C; Balbo SL; Ribeiro RA; Vettorazzi JF; Santos-Silva JC; Carneiro EM; Bonfleur ML
Braz J Med Biol Res; 2015 May; 48(5):447-57. PubMed ID: 25714886
[TBL] [Abstract][Full Text] [Related]
32. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
33. Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats.
Chang WC; Wu JS; Chen CW; Kuo PL; Chien HM; Wang YT; Shen SC
Nutrients; 2015 Dec; 7(12):9946-59. PubMed ID: 26633482
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness.
Lystedt E; Westergren H; Brynhildsen J; Lindh-Astrand L; Gustavsson J; Nystrom FH; Hammar M; Strålfors P
Eur J Endocrinol; 2005 Dec; 153(6):831-5. PubMed ID: 16322388
[TBL] [Abstract][Full Text] [Related]
35. [Pathophysiologic principles of metabolic syndrome. Consequences for early diagnosis and prevention].
Häring HU
Fortschr Med; 1992 Dec; 110(34):633-6. PubMed ID: 1483614
[TBL] [Abstract][Full Text] [Related]
36. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
Rett K; Wicklmayr M; Standl E
Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
[TBL] [Abstract][Full Text] [Related]
37. Leptin deficiency in rats results in hyperinsulinemia and impaired glucose homeostasis.
D'souza AM; Asadi A; Johnson JD; Covey SD; Kieffer TJ
Endocrinology; 2014 Apr; 155(4):1268-79. PubMed ID: 24467741
[TBL] [Abstract][Full Text] [Related]
38. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia.
Kim SP; Catalano KJ; Hsu IR; Chiu JD; Richey JM; Bergman RN
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1590-8. PubMed ID: 17264230
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
[TBL] [Abstract][Full Text] [Related]
40. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
Brun JF; Aloulou I; Varlet-Marie E
Clin Hemorheol Microcirc; 2004; 30(3-4):203-9. PubMed ID: 15258344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]